<DOC>
	<DOCNO>NCT01229202</DOCNO>
	<brief_summary>Vascular epithelial growth factor ( VEGF ) play critical role vessel growth wound heal . Bevacizumab , non specific VEGF inhibitor , successfully use treatment eye disease associate neovascularization . The purpose randomize study 1 ) investigate effect intraoperative subtenon injection bevacizumab outcomes trabeculectomy surgery . 2 ) measure plasma aqueous level VEGF ass association outcomes trabeculectomy surgery . Trabeculectomy surgery , small drainage canal create front eye , common glaucoma surgery perform worldwide . The goal surgery control intraocular pressure . Failure procedure commonly cause excessive scarring surgical site . If scarring occurs , drainage canal close . By add Bevacizumab time surgery , wound healing may slow surgical failure prevent . The result study helpful future development new effective safe surgical technique treatment glaucoma . Patients give informed consent randomize two group . One group receive standard care trabeculectomy surgery group receive standard care plus injection Bevacizumab surgery site . Both group one time collection ocular fluid blood sample take vein arm . After surgery , patient see study doctor six time follow year . At visit measurement take visual acuity , eye pressure blood pressure . The doctor clinical exam month six twelve photographs patient ' eye take .</brief_summary>
	<brief_title>Use Bevacizumab Modulate Outcomes Trabeculectomy Surgery</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<criteria>type glaucoma , except neovascular inflammatory patient require trabeculectomy combine cataract surgery trabeculectomy surgery young 30 year age previous ocular surgery except cataract surgery patient present intraocular inflammation neovascular glaucoma patient aphakic diabetic retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>trabeculectomy</keyword>
	<keyword>glaucoma surgery</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>Vascular Endothelial Growth Inhibitor</keyword>
	<keyword>glaucoma</keyword>
</DOC>